$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
6 Biotech/Drug Stocks Up Manifold in 2020 Thanks to COVID-19
11:18am, Thursday, 24'th Dec 2020
We discuss six biotech/drug stocks, NVAX, VXRT, MRNA, TBIO, INO and BNTX that have more than doubled in 2020 on the back of their progress in coronavirus vaccine development.
Inovio Shares Rise On Positive Data For Coronavirus Vaccine Candidate That's Stable At Room Temps
11:04am, Thursday, 24'th Dec 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were trading higher Thursday after the company released positive Phase 1 data on to its COVID-19 DNA vaccine candidate. What Happened: On Wednesday, I
INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedicine
09:14am, Thursday, 24'th Dec 2020
PLYMOUTH MEETING, Pa., Dec. 24, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infect
3 Wild-Card Stocks for the New Bull Market
06:53am, Saturday, 19'th Dec 2020
These stocks could shine next year, assuming they don't stumble beforehand.
Are Options Traders Betting on a Big Move in Inovio Pharmaceuticals (INO) Stock?
09:47am, Thursday, 17'th Dec 2020
Investors need to pay close attention to Inovio Pharmaceuticals (INO) stock based on the movements in the options market lately.
Should Investors Buy Inovio for Its Coronavirus Vaccine?
02:40pm, Sunday, 13'th Dec 2020
The biotech is trailing the leaders.
These 5 Mid-Cap Healthcare Stocks Had the Best Gains in 2020
06:45am, Friday, 11'th Dec 2020
Investors favored coronavirus vaccine work, late-stage trial victories, and genetic sequencing.
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Anal Dysplasia Caused by HPV-16/18
08:00am, Wednesday, 09'th Dec 2020
PLYMOUTH MEETING, Pa., Dec. 9, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infecti
Inovio starts dosing participants in mid-stage COVID-19 vaccine trial
09:23am, Monday, 07'th Dec 2020
Shares of Inovio Pharmaceuticals Inc. gained 0.6% in premarket trading on Monday after the company said it started dosing participants in a Phase 2 clinical trial for its experimental COVID-19 vaccine
Why Coronavirus Stock Inovio Pharmaceuticals Shot Higher Today
05:53pm, Thursday, 03'rd Dec 2020
The company taps another partner to help make its coronavirus vaccine when, and if, it's approved.
Inovio Strikes Coronavirus Vaccine Manufacturing Deal With Kaneka Unit
03:34pm, Thursday, 03'rd Dec 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO), which is developing a DNA vaccine against SARS-CoV-2, issued an update on its vaccine program Thursday, sending the stock higher. What Happened: The Plymout
Just Say No to Inovio Pharmaceuticals Stock
08:15am, Wednesday, 02'nd Dec 2020
While INO stock has boasted a banner year, Inovio appears no closer to a Covid-19 vaccine than any of the other 150 contenders. The post Just Say No to Inovio Pharmaceuticals Stock appeared first on I
4 Pharmaceutical Stocks That Aren't Worth Their Outsized 2020 Gains
01:01pm, Tuesday, 01'st Dec 2020
Now that companies such as Pfizer, Moderna and AstraZeneca have emerged with viable vaccines against Covid-19, the hype around many pharmaceutical stocks is fading. Here are four stocks investors shou
Is Inovio Pharmaceuticals a Buy?
07:00am, Tuesday, 01'st Dec 2020
A potential coronavirus vaccine isn't the only promising pipeline candidate for this small-cap biotech.
Count on the Advancement of DNA Medicine with Inovio Stock
03:41pm, Monday, 30'th Nov 2020
If you're thinking that INO stock is just a wager on a Covid-19 vaccine candidate, think again. Inovio's pipeline is robust and diverse.
Sign In
Buy INO